Minor Use Minor Species Development of Drugs
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.
Drug companies rarely bother developing a new drug for a rare animal disease or an uncommon species, because the market is too small to cover the cost of the safety and effectiveness testing FDA approval requires.
This is FDA's Center for Veterinary Medicine (CVM) reimbursing the cost of that testing for animal drugs designated under the Minor Use Minor Species (MUMS) programme — drugs for minor …
Research Project (R01) grants reimbursing the safety and effectiveness testing costs of new animal drugs designated for minor uses in major species or for minor species, for applicants who already hold an open Investigational New Animal Drug file and a MUMS designation with FDA's Center for Veterinary Medicine.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up